Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK and Safety of DA-5206 vs Talion in Healthy Males
NCT03200496Phase 1Completed
- Sponsor
- Dong-A ST
- Start
- May 2017
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of bepotastine in allergic rhinitis (AR) and urticaria (3 arms), sponsored by Dong-A ST. Primary endpoints: Area under the plasma concentration versus time curve and Peak Plasma Concentration. Started May 2017; status: completed.
02
Drugs
bepotastine
03
Conditions
allergic rhinitis (AR)urticaria
Beyond the preview
Go deeper on NCT03200496.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03200496.